Equities

PainReform Ltd

PRFX:NAQ

PainReform Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.71
  • Today's Change0.00 / 0.00%
  • Shares traded12.28k
  • 1 Year change-84.57%
  • Beta0.6638
Data delayed at least 15 minutes, as of May 31 2024 20:59 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

  • Revenue in USD (TTM)0.00
  • Net income in USD-12.54m
  • Incorporated2007
  • Employees6.00
  • Location
    PainReform Ltd65 Yigal Alon St.TEL AVIV-YAFO 6744316IsraelISR
  • Phone+972 37177051
  • Fax+972 99542266
  • Websitehttps://painreform.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Bluejay Diagnostics Inc0.00-9.74m1.54m10.00--0.4232-----7.68-7.680.001.250.00----0.00-122.06---149.68--------------0.0048---100.00---7.07------
Finch Therapeutics Group Inc0.00-16.28m1.55m18.00--0.0816-----10.14-10.140.0011.860.00-------25.22---28.97--------------0.00---87.57--34.80------
InVitro International716.89k6.22k1.57m16.00197.342.15--2.190.00040.00040.04020.03211.15------0.9957.891.098.83----0.86765.90---------5.111.33-87.77-16.14----
Target Group Inc5.64m228.87k1.57m46.0019.62--1.480.2790.00010.00010.0088-0.01150.7648.60124.27115,104.103.10-37.99---78.7643.71--4.06-586.970.07360.01493.10----577.8392.84---58.54--
Mallinckrodt PLC1.91bn-1.49bn1.60m2.80k------0.0008-161.65-161.6389.6355.440.40621.574.94681,821.40-31.61-12.49-36.10-15.8526.2235.68-77.83-44.381.63-0.34560.6164---2.53-10.31-83.00------
Procyon Corp4.77m-387.79k1.62m17.00--0.764--0.3397-0.0478-0.04780.58910.27741.391.949.60280,817.70-10.813.52-13.694.2378.0173.30-7.782.522.22--0.00---3.223.1170.44--30.98--
Stemcell Holdings Inc9.98m3.10m1.64m------0.50080.16450.000080.000080.00030.00021.12--5.20--34.90--68.19--77.19--31.04------0.00--85.10--71.82------
Dermata Therapeutics Inc0.00-8.69m1.70m8.00--6.71-----24.67-24.670.000.57170.00----0.00-120.05---146.08--------------0.00------18.90------
Qualigen Therapeutics Inc0.00-12.48m1.70m4.00---------2.46-2.640.00-0.39230.00----0.00-118.15---364.72--21.30---------7.41--------10.22------
PainReform Ltd0.00-12.54m1.76m6.00--0.7109-----7.77-7.770.000.99880.00----0.00-158.88-55.47-222.89-68.20------------0.00-------6.28------
Hi-Great Group Holding Co109.49k-121.76k1.78m--------16.26-0.0012-0.00120.0011-0.00110.82240.8406-----91.46------46.50---111.21--0.0144-52.41-----47.32---3,789.70------
SYBLEU Inc11.70k-307.88k1.84m--------157.17-0.0293-0.02930.0011-0.03670.0641-------168.63-----------2,631.45-----8.484.96--0.00--26.51------
SOHM Inc-100.00bn-100.00bn1.84m--------------------------------------------------------------
CanaQuest Medical Corp0.00-808.07k1.92m-----------0.0514-0.05140.00-0.0370.00-------1,084.38--------------------------57.42------
Panbela Therapeutics Inc0.00-27.26m1.94m7.00---------20.38-20.380.00-0.65630.00----0.00-201.94-215.89-809.38-476.38-----------161.794.16------27.68------
Twinlab Consolidated Holdings Inc12.65m-9.55m1.94m17.00------0.1537-0.0369-0.05020.0488-0.54471.011.497.30743,941.20-76.13-60.53----34.5921.36-75.51-37.720.0094-0.0108-----20.87-28.58-20.28------
Data as of May 31 2024. Currency figures normalised to PainReform Ltd's reporting currency: US Dollar USD

Institutional shareholders

7.20%Per cent of shares held by top holders
HolderShares% Held
Armistice Capital LLCas of 31 Mar 2024156.00k6.31%
Citadel Securities LLCas of 31 Mar 202417.15k0.69%
Osaic Wealth, Inc. (Investment Management)as of 31 Mar 20244.60k0.19%
UBS Securities LLCas of 31 Mar 2024474.000.02%
G1 Execution Services LLCas of 31 Mar 20240.000.00%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.